SK-Pharma is a global pharmaceutical company focusing on making drugs accessible to patients in needs. The vison of the company lay in utilizing cutting edge technologies to support smart business decisions that will lead to better healthcare solutions. Taking patient centric approach, the company holistically follow the patients journey and understand better their unmet needs. Mimicking the patient journey allow us to come with viable solutions that change the patient treatment paradigm and make it more suitable to their lifestyle and their unique needs. Treating a debilitating condition doesn’t have to impose a big impact on patients and caregivers life. In SK we follow this vision rigorously by leveraging technology to gauge the latest drug development and matching it to patient’s needs. The group is divided to three divisions: First to launch and the introduction of complex hybrid generic products. The second division is focusing on providing technological solutions to enhance smart business decisions. The third division is specialized in orphan drugs market access and distribution worldwide Our mission is to improve wellbeing by allowing accessible medicines to all patients in needs. At SK-Pharma our core business is to launch complex and non-infringing generic medicines in the markets of interest, such as Israel & Palestinian Authority, CIS, GCC Balkans and Latin America. Additionally, our company provide access through name patient program for pediatric and orphan products as well as providing products that are difficult to access to thousands of patients globally. Utilizing our technological capabilities enables SK-Pharma team the ability, to apply cutting edge technologies, to offer smart and timely solutions for product selection, launch strategies and supply mitigating. SK team synergistically engage to support our mission to lead the industry by providing unique, practical and timely solutions.